CEFPODOXIME PROXETIL Drug Patent Profile
✉ Email this page to a colleague
When do Cefpodoxime Proxetil patents expire, and what generic alternatives are available?
Cefpodoxime Proxetil is a drug marketed by Aurobindo Pharma Ltd, Chartwell Rx, Sun Pharm Inds Ltd, Alkem Labs Ltd, Anda Repository, Aurobindo Pharma, and Sandoz. and is included in eight NDAs.
The generic ingredient in CEFPODOXIME PROXETIL is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefpodoxime Proxetil
A generic version of CEFPODOXIME PROXETIL was approved as cefpodoxime proxetil by AUROBINDO PHARMA LTD on June 8th, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFPODOXIME PROXETIL?
- What are the global sales for CEFPODOXIME PROXETIL?
- What is Average Wholesale Price for CEFPODOXIME PROXETIL?
Summary for CEFPODOXIME PROXETIL
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,195 |
| Drug Prices: | Drug price information for CEFPODOXIME PROXETIL |
| DailyMed Link: | CEFPODOXIME PROXETIL at DailyMed |
Recent Clinical Trials for CEFPODOXIME PROXETIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Entasis Therapeutics | Phase 1 |
| University of Louisville | Early Phase 1 |
| James Graham Brown Cancer Center | Early Phase 1 |
Pharmacology for CEFPODOXIME PROXETIL
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFPODOXIME PROXETIL
US Patents and Regulatory Information for CEFPODOXIME PROXETIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | CEFPODOXIME PROXETIL | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 065409-001 | Jun 8, 2007 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alkem Labs Ltd | CEFPODOXIME PROXETIL | cefpodoxime proxetil | TABLET;ORAL | 210568-001 | May 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | CEFPODOXIME PROXETIL | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 090031-002 | Jan 14, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
